Welcome to LookChem.com Sign In|Join Free
  • or
3,3'-Diselenobispropionic acid, a diselenide compound with the molecular formula C6H10O4Se2, is characterized by its unique structure featuring two selenium atoms connected by a propionic acid group. 3,3'-Diselenobispropionic acid is a significant constituent in the formulation of selenium-based pharmaceuticals and has demonstrated therapeutic potential for a range of diseases, including cancer and viral infections. Its antioxidant capabilities and research into its role in mitigating oxidative stress and inflammation further underscore its value. Moreover, 3,3'-Diselenobispropionic acid has been explored for nanotechnology applications, particularly in the creation of selenium-enriched nanoparticles for medical use, highlighting its multifaceted utility in both therapeutic and industrial realms.

7370-58-3

Post Buying Request

7370-58-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7370-58-3 Usage

Uses

Used in Pharmaceutical Development:
3,3'-Diselenobispropionic acid is utilized as a key component in the development of selenium-based drugs, leveraging its potential as a therapeutic agent for the treatment of various diseases such as cancer and viral infections.
Used in Antioxidant and Anti-Inflammatory Applications:
3,3'-Diselenobispropionic acid is employed as an antioxidant to reduce oxidative stress and inflammation in the body, contributing to overall health and well-being.
Used in Nanotechnology:
3,3'-Diselenobispropionic acid is used in the synthesis of selenium-containing nanoparticles for biomedical purposes, indicating its significance in advancing nanotechnology applications in medicine.

Check Digit Verification of cas no

The CAS Registry Mumber 7370-58-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,3,7 and 0 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7370-58:
(6*7)+(5*3)+(4*7)+(3*0)+(2*5)+(1*8)=103
103 % 10 = 3
So 7370-58-3 is a valid CAS Registry Number.

7370-58-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(2-carboxyethyldiselanyl)propanoic acid

1.2 Other means of identification

Product number -
Other names Diselenium-dipropionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7370-58-3 SDS

7370-58-3Synthetic route

3-Bromopropionic acid
590-92-1

3-Bromopropionic acid

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Conditions
ConditionsYield
With sodium diselenide In water at 20℃; for 3h; Inert atmosphere;87%
With selenium; sodium tetrahydroborate; water; sodium carbonate at 20℃; for 12h; pH=8; Inert atmosphere;62%
With disodium diselenide52%
chloropropionic acid
107-94-8

chloropropionic acid

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Conditions
ConditionsYield
With selenium; sodium tetrahydroborate In water at 25℃; for 16h;81.3%
β-Propiolactone
57-57-8

β-Propiolactone

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Conditions
ConditionsYield
With sodium selenide; water
3-selenocyanatopropanoic acid
18207-08-4

3-selenocyanatopropanoic acid

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Conditions
ConditionsYield
With hydrogenchloride
hydrogenchloride
7647-01-0

hydrogenchloride

3-selenocyanatopropanoic acid
18207-08-4

3-selenocyanatopropanoic acid

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

potassium salt of/the/ 3-chloro-propionic acid

potassium salt of/the/ 3-chloro-propionic acid

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Conditions
ConditionsYield
With potassium selenide; water
chloropropionic acid
107-94-8

chloropropionic acid

sodium diselenide

sodium diselenide

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Conditions
ConditionsYield
at 20℃; for 4h; pH=8; Inert atmosphere;
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

aniline
62-53-3

aniline

3,3′-diselanediylbis(N-phenylpropanamide)

3,3′-diselanediylbis(N-phenylpropanamide)

Conditions
ConditionsYield
Stage #1: 3,3'-diselenodipropanoic acid With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 2h;
Stage #2: aniline at 20℃; for 14h;
80%
Stage #1: 3,3'-diselenodipropanoic acid With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 2h; Cooling with ice;
Stage #2: aniline at 20℃; for 14h;
80%
bis(η3-allyl-μ-chloropalladium(II))

bis(η3-allyl-μ-chloropalladium(II))

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

[Pd(μ-SeCH2CH2COOH)(η3-C3H5)]3

[Pd(μ-SeCH2CH2COOH)(η3-C3H5)]3

Conditions
ConditionsYield
With NaBH4 In water; acetone to soln. Pd complex in acetone aq. soln. NaSeCH2CH2COOH prepared in situby reaction (SeCH2CH2COOH)2 with NaBH4 soln. Pd complex was added, stir red for 0.5 h; ppt. was filtered and washed with ether; elem. anal.;78%
1-(2-hydroxyethyl)-1H-pyrrole-2,5-dione
1585-90-6

1-(2-hydroxyethyl)-1H-pyrrole-2,5-dione

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

bis(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl) 3,3'-diselanediyldipropionate

bis(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl) 3,3'-diselanediyldipropionate

Conditions
ConditionsYield
Stage #1: 1-(2-hydroxyethyl)-1H-pyrrole-2,5-dione With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 0.5h;
Stage #2: 3,3'-diselenodipropanoic acid In dichloromethane at 0 - 20℃; for 24.5h;
75%
Stage #1: 1-(2-hydroxyethyl)-1H-pyrrole-2,5-dione With dmap; dicyclohexyl-carbodiimide for 0.5h; Steglich Esterification; Cooling with ice;
Stage #2: 3,3'-diselenodipropanoic acid at 20℃; for 24.5h; Steglich Esterification; Cooling with ice;
70%
Stage #1: 1-(2-hydroxyethyl)-1H-pyrrole-2,5-dione With dmap; dicyclohexyl-carbodiimide In dichloromethane for 0.5h; Cooling with ice;
Stage #2: 3,3'-diselenodipropanoic acid In dichloromethane at 20℃; for 24.5h; Cooling with ice;
63%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

propargyl alcohol
107-19-7

propargyl alcohol

dipropargyl 3,3-diselenium dipropionate

dipropargyl 3,3-diselenium dipropionate

Conditions
ConditionsYield
Stage #1: propargyl alcohol With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 0.5h; Cooling with ice;
Stage #2: 3,3'-diselenodipropanoic acid In tetrahydrofuran at 20℃; for 24.5h; Cooling with ice;
68.5%
methanol
67-56-1

methanol

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

diselenodipropionic acid dimethyl ester
136397-82-5

diselenodipropionic acid dimethyl ester

Conditions
ConditionsYield
With sulfuric acid for 24h; Heating;68%
With sulfuric acid; benzene unter Entfernen des entstehenden Wassers;
furan-2-ylmethanamine
617-89-0

furan-2-ylmethanamine

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

C16H20N2O4Se2

C16H20N2O4Se2

Conditions
ConditionsYield
Stage #1: furan-2-ylmethanamine With dicyclohexyl-carbodiimide In dichloromethane for 0.5h; Cooling with ice;
Stage #2: 3,3'-diselenodipropanoic acid In dichloromethane at 20℃; for 24.5h; Cooling with ice;
67%
ethylenediamine platinum(II) nitrate
50475-22-4

ethylenediamine platinum(II) nitrate

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Pt(H2NC2H4NH2)((OOCC2H4Se)2)
1367708-23-3

Pt(H2NC2H4NH2)((OOCC2H4Se)2)

Conditions
ConditionsYield
With NaOH In water to stirred soln. of Pt-complex aq. NaOH added slowly, stirred for ca. 20min, acid added at room temp., stirred for 2 h; soln. concd. (vac.), ppt. washed (ethanol), dried (vac.), recrystd. (H2O/ethanol); elem. anal.;65%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

Propargylamine
2450-71-7

Propargylamine

C12H16N2O2Se2

C12H16N2O2Se2

Conditions
ConditionsYield
Stage #1: Propargylamine With dicyclohexyl-carbodiimide In dichloromethane for 0.5h; Cooling with ice;
Stage #2: 3,3'-diselenodipropanoic acid In dichloromethane at 20℃; for 24.5h; Cooling with ice;
65%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

cholesterol
57-88-5

cholesterol

C60H98O4Se2

C60H98O4Se2

Conditions
ConditionsYield
Stage #1: 3,3'-diselenodipropanoic acid With dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 0.166667h; Inert atmosphere;
Stage #2: With dmap In dichloromethane for 0.25h; Inert atmosphere;
Stage #3: cholesterol In dichloromethane at 20℃; Inert atmosphere;
64%
[Pd2Cl2(μ-Cl)2(P-n-Pr3)2]

[Pd2Cl2(μ-Cl)2(P-n-Pr3)2]

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

A

[Pd2Cl2(μ-SeCH2CH2COOH)2(PnPr3)2]

[Pd2Cl2(μ-SeCH2CH2COOH)2(PnPr3)2]

B

[Pd3Cl2(μ-SeCH2CH2COOH)4(PnPr3)2]

[Pd3Cl2(μ-SeCH2CH2COOH)4(PnPr3)2]

Conditions
ConditionsYield
With NaBH4; aq. NH3; conc. H2SO4 In water; acetone (SeCH2CH2COOH)2, NaBH4, NH3 soln., distilled water mixed, stirred under Ar, conc. H2SO4 added, acetone soln. of Pd complex added, stirred for 1 h at room temp.; evapd. under vac., residue washed with water, dried under vac., extracted with CH2Cl2, filtered, concentrated, layered with hexane-acetone, cooled, detd. by (1)H NMR, (31)P NMR, (77)Se NMR, elem.anal.;A 60%
B 8%
7-hydroxy-2H-chromen-2-one
93-35-6

7-hydroxy-2H-chromen-2-one

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

C24H18O8Se2

C24H18O8Se2

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 16h; Inert atmosphere;60%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

2Pd(2+)*4Cl(1-)*2P(CH3)(C6H5)2=[Pd2Cl4(P(CH3)(C6H5)2)2]

2Pd(2+)*4Cl(1-)*2P(CH3)(C6H5)2=[Pd2Cl4(P(CH3)(C6H5)2)2]

2Pd(2+)*2Cl(1-)*2SeCH2CH2C(O)OH(1-)*2P(CH3)(C6H5)2=[Pd2Cl2(SeCH2CH2COOH)2(P(CH3)(C6H5)2)2]

2Pd(2+)*2Cl(1-)*2SeCH2CH2C(O)OH(1-)*2P(CH3)(C6H5)2=[Pd2Cl2(SeCH2CH2COOH)2(P(CH3)(C6H5)2)2]

Conditions
ConditionsYield
With NaBH4; aq. NH3; conc. H2SO4 In water; acetone (SeCH2CH2COOH)2, NaBH4, NH3 soln., distilled water mixed, stirred under Ar, conc. H2SO4 added, acetone soln. of Pd complex added, stirred for 1 h at room temp.; evapd. under vac., residue washed with water, dried under vac., extracted with CH2Cl2, filtered, concentrated, layered with hexane-acetone, cooled, detd. by (1)H NMR, (31)P NMR, (77)Se NMR, elem.anal., XRD;54%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

C18H22N4O2Se2
1639895-72-9

C18H22N4O2Se2

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In acetonitrile at 20℃; Inert atmosphere;54%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

4-(aminomethyl)benzonitrile hydrochloride

4-(aminomethyl)benzonitrile hydrochloride

3,3'-diselanediylbis(N-(4-cyanobenzyl)propanamide)

3,3'-diselanediylbis(N-(4-cyanobenzyl)propanamide)

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran; dichloromethane at 0 - 20℃; for 0.208333h; Inert atmosphere;52%
[Pt2Cl2(μ-Cl)2(P-n-Pr3)2]

[Pt2Cl2(μ-Cl)2(P-n-Pr3)2]

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

[Pt2Cl2(μ-SeCH2CH2COOH)2(PnPr3)2]

[Pt2Cl2(μ-SeCH2CH2COOH)2(PnPr3)2]

Conditions
ConditionsYield
With NaBH4; aq. NH3; conc. H2SO4 In water; acetone (SeCH2CH2COOH)2, NaBH4, NH3 soln., distilled water mixed, stirred under Ar, conc. H2SO4 added, acetone soln. of Pt complex added, stirred for 1 h at room temp.; evapd. under vac., residue washed with water, dried under vac., extracted with CH2Cl2, filtered, concentrated, layered with hexane-acetone, cooled, detd. by (1)H NMR, (31)P NMR, (77)Se NMR, (195)Pt NMR, elem.anal.;50%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

3,3'-diselenodipropionic anhydride

3,3'-diselenodipropionic anhydride

Conditions
ConditionsYield
With acetyl chloride at 65℃; for 2h;49.3%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

2-amino-phenol
95-55-6

2-amino-phenol

C18H20N2O4Se2
1639895-71-8

C18H20N2O4Se2

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In acetonitrile at 20℃; Inert atmosphere;36%
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

C100H108N2O30Se2

C100H108N2O30Se2

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 1h;35%
propan-1-ol
71-23-8

propan-1-ol

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

4,5-diselena-octanedioic acid dipropyl ester

4,5-diselena-octanedioic acid dipropyl ester

Conditions
ConditionsYield
With sulfuric acid; benzene unter Entfernen des entstehenden Wassers;
2-ethoxy-ethanol
110-80-5

2-ethoxy-ethanol

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

4,5-diselena-octanedioic acid bis-(2-ethoxy-ethyl ester)

4,5-diselena-octanedioic acid bis-(2-ethoxy-ethyl ester)

Conditions
ConditionsYield
With sulfuric acid; benzene unter Entfernen des entstehenden Wassers;
ethanol
64-17-5

ethanol

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

bis(2-carboxyethylethyl) diselenide
86247-54-3

bis(2-carboxyethylethyl) diselenide

Conditions
ConditionsYield
With sulfuric acid; benzene unter Entfernen des entstehenden Wassers;
2-methoxy-ethanol
109-86-4

2-methoxy-ethanol

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

4,5-diselena-octanedioic acid bis-(2-methoxy-ethyl ester)

4,5-diselena-octanedioic acid bis-(2-methoxy-ethyl ester)

Conditions
ConditionsYield
With sulfuric acid; benzene unter Entfernen des entstehenden Wassers;
2-Butoxyethanol
111-76-2

2-Butoxyethanol

3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

4,5-diselena-octanedioic acid bis-(2-butoxy-ethyl ester)

4,5-diselena-octanedioic acid bis-(2-butoxy-ethyl ester)

Conditions
ConditionsYield
With sulfuric acid; benzene unter Entfernen des entstehenden Wassers;
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

(+/-)-2-methyl-3-selena-adipic acid
20846-73-5

(+/-)-2-methyl-3-selena-adipic acid

Conditions
ConditionsYield
With sodium amalgam Behandlung mit 2-Brom-propionsaeure in neutraler wss.Loesung;
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

3-selenino-propionic acid
55509-78-9

3-selenino-propionic acid

Conditions
ConditionsYield
With dihydrogen peroxide; acetone
With nitric acid at 45℃;
3,3'-diselenodipropanoic acid
7370-58-3

3,3'-diselenodipropanoic acid

butan-1-ol
71-36-3

butan-1-ol

4,5-diselena-octanedioic acid dibutyl ester

4,5-diselena-octanedioic acid dibutyl ester

Conditions
ConditionsYield
With sulfuric acid; benzene unter Entfernen des entstehenden Wassers;

7370-58-3Relevant academic research and scientific papers

Selenosulfides Tethered to gem-Dimethyl Esters: A Robust and Highly Versatile Framework for H2S Probe Development

Suarez, S. Israel,Ambrose, Rynne,Kalk, Madison A.,Lukesh, John C.

, p. 15736 - 15740 (2019)

Selenosulfides coupled to gem-dimethyl esters provide an exceptional platform for H2S probe development. With the sulfur half being nonessential to its high reactivity and selectivity towards H2S, we highlight the unique flexibility of our design by improving its biocompatibility and tissue specificity through structural modifications of its sulfide moiety.

Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor

Xu, Jingwen,Yan, Xiangji,Ge, Xin,Zhang, Mingzhen,Dang, Xugang,Yang, Yan,Xu, Feng,Luo, Yanling,Li, Guoliang

, p. 1297 - 1314 (2021)

The efficacy of ongoing anticancer treatment is often compromised by some barriers, such as low drug content, nonspecific release of drug delivery system, and multidrug resistance (MDR) effect of tumors. Herein, in the research a novel functionalized PEG-based polymer cystine-(polyethylene glycol)2-b-(poly(2-methacryloyloxyethyl ferrocenecarboxylate)2) (Cys-(PEG45)2-b-(PMAOEFC)2) with multi-stimuli sensitive mechanism was constructed, in which doxorubicin (DOX) was chemical bonded through Schiff base structure to provide acid labile DOX prodrug (DOX)2-Cys-(PEG45)2-b-(PMAOEFC)2. Afterwards, paclitaxel (PTX) and its diselenide bond linked PTX dimer were encapsulated into the prodrug through physical loading, to achieve pH and triple redox responsive (DOX)2-Cys-(PEG45)2-b-(PMAOEFC)2@PTXand (DOX)2-Cys-(PEG45)2-b-(PMAOEFC)2@PTX?dimerwith ultrahigh drugs content. The obtained nanovehicles could self-assemble into globular micelles with good stability based on fluorescence spectra and TEM observation. Moreover, there was a remarkable “reassembly-disassembly” behavior caused by phase transition of micelles under the mimic cancerous physiological environment. DOX and PTX could be on-demand released in acid and redox stress mode, respectively. Meanwhile,in vivoanticancer studies revealed the significant tumor inhibition of nanoformulas. This work offered facile strategies to fabricate drug nanaovehicles with tunable drug content and types, it has a profound significance in overcoming MDR effect, which provided more options for sustainable cancer treatment according to the desired drug dosage and the stage of tumor growth.

Fabrication of redox-responsive Bi(mPEG-PLGA)-Se2 micelles for doxorubicin delivery

Birhan, Yihenew Simegniew,Hailemeskel, Balkew Zewge,Mekonnen, Tefera Worku,Hanurry, Endiries Yibru,Darge, Haile Fentahun,Andrgie, Abegaz Tizazu,Chou, Hsiao-Ying,Lai, Juin-Yih,Hsiue, Ging-Ho,Tsai, Hsieh-Chih

, (2019)

Stimuli-responsive polymeric nanostructures have emerged as potential drug carriers for cancer therapy. Herein, we synthesized redox-responsive diselenide bond containing amphiphilic polymer, Bi(mPEG-PLGA)-Se2 from mPEG-PLGA and 3,3′-diselanediyldipropanoic acid (DSeDPA) using DCC/DMAP as coupling agents. Due to its amphiphilic nature, Bi(mPEG-PLGA)-Se2 self-assembled in to stable micelles in aqueous solution with a hydrodynamic size of 123.9 ± 0.85 nm. The Bi(mPEG-PLGA)-Se2 micelles exhibited DOX-loading content (DLC) of 6.61 wt% and encapsulation efficiency (EE) of 54.9%. The DOX-loaded Bi(mPEG-PLGA)-Se2 micelles released 73.94% and 69.54% of their cargo within 72 h upon treatment with 6 mM GSH and 0.1% H2O2, respectively, at pH 7.4 and 37 °C. The MTT assay results demonstrated that Bi(mPEG-PLGA)-Se2 was devoid of any inherent toxicity and the DOX-loaded micelles showed pronounced antitumor activities against HeLa cells, 44.46% of cells were viable at maximum dose of 7.5 μg/mL. The cellular uptake experiment further confirmed the internalization of DOX-loaded Bi(mPEG-PLGA)-Se2 micelles and endowed redox stimuli triggered drug release in cytosol and nuclei of cancer cells. Overall, the results suggested that the smart, biocompatible Bi(mPEG-PLGA)-Se2 copolymer could serve as potential drug delivery biomaterial for the controlled release of hydrophobic drugs in cancer cells.

NIR responsive cross-linked micelles, drug delivery carrier targeting cancer cell and method for preparing the same

-

Paragraph 0192-0194, (2020/07/28)

The present invention relates to: a cross-linked micelle having a cancer cell target function in response to near infrared rays; a drug delivery carrier comprising the same; and a method for manufacturing the same. The drug delivery carrier having the cancer cell target function that induces drug release by using near infrared rays can be easily manufactured by a click reaction, and actively releases drugs from the outside by specifically targeting cancer cells, thereby being able to specifically kill cancer cells. Therefore, the drug delivery carrier can be usefully used in the pharmaceutical field.COPYRIGHT KIPO 2020

Synthesis of functionalized organoselenium materials: Selenides and diselenides containing cholesterol

Frizon, Tiago E.,Rafique, Jamal,Saba, Sumbal,Bechtold, Ivan H.,Gallardo, Hugo,Braga, Antonio L.

supporting information, p. 3470 - 3476 (2015/06/08)

Abstract A simple and efficient procedure for the synthesis of three new series of chalcogen liquid crystals, based on selenides and diselenides, containing cholesterol in their structure, is described. Thermal and liquid crystalline properties were investigated by POM, DSC, TGA and XRD scattering. Six of the nine molecules synthesized showed liquid crystal properties, with smectic mesomorphism. All the compounds presented good thermal stability. The smectic mesomorphism was confirmed through XRD analysis. The morphology of the surface of the films was investigated by using atomic force microscopy (AFM). All prepared diselenides showed good glutathione peroxidase like activity and one of the diselenides was 3.3 times more active than the standard Ebselen.

Synthesis and biological evaluation of 2-picolylamide-based diselenides with non-bonded interactions

Rafique, Jamal,Saba, Sumbal,Canto, Rmulo Faria Santos,Frizon, Tiago Elias Allievi,Hassan, Waseem,Waczuk, Emily Pansera,Jan, Maryam,Back, Davi Fernando,Rocha, Joo Batista Teixeira Da,Braga, Antonio Luiz

, p. 10095 - 10109 (2015/08/06)

In this paper, we report the synthesis and biological evaluation of picolylamide-based diselenides with the aim of developing a new series of diselenides with O???Se non-bonded interactions. The synthesis of diselenides was performed by a simple and efficient synthetic route. All the products were obtained in good yields and their structures were determined by 1H-NMR, 13C-NMR and HRMS. All these new compounds showed promising activities when tested in different antioxidant assays. These amides exhibited strong thiol peroxidase-like (TPx) activity. In fact one of the compounds showed 4.66 times higher potential than the classical standard i.e., diphenyl diselenide. The same compound significantly inhibited iron (Fe)-induced thiobarbituric acid reactive species (TBARS) production in rat's brain homogenate. In addition, the X-ray structure of the most active compound showed non-bonded interaction between the selenium and the oxygen atom that are in close proximity and may be responsible for the increased antioxidant activity. The present study provides evidence about the possible biochemical influence of nonbonding interactions on organochalcogens potency.

Synthesis and biological evaluation of new nitrogen-containing diselenides

Nascimento, Vanessa,Ferreira, Natasha L.,Canto, R?mulo F.S.,Schott, Karen L.,Waczuk, Emily P.,Sancineto, Luca,Santi, Claudio,Rocha, Jo?o B.T.,Braga, Antonio L.

, p. 131 - 139 (2015/02/19)

The antioxidant properties of organoselenium compounds have been extensively investigated with the aim of developing new drugs, since oxidative stress is responsible for a variety of chronic human diseases. Herein, we reported the synthesis of new nitrogen-containing diselenides by a simple and efficient synthetic route. The products were obtained in good to excellent yields and their identification and characterization were achieved by NMR and HRMS techniques. The new derivatives may represent promising structures with different biological activities, which can act against oxidative stress through diverse mechanisms of action. The glutathione peroxidase-like assay (GPx-like activity) of the new synthesized compounds indicated that they reduced H2O2to water at the expense of PhSH. The best results were obtained with diselenide 2b, which was 9 times more active than the standard organoselenium drug ebselen and, in contrast, this compound was not reduced by hepatic TrxR. All of the new compounds inhibited Fe(II)-induced TBARS.

Diselenides and Allyl Selenides as Glutathione Peroxidase Mimetics. Remarkable Activity of Cyclic Seleninates Produced in Situ by the Oxidation of Allyl ω-Hydroxyalkyl Selenides

Back, Thomas G.,Moussa, Ziad

, p. 13455 - 13460 (2007/10/03)

A series of aliphatic diselenides and selenides containing coordinating substituents was tested for glutathione peroxidase (GPx)-like catalytic activity in a model system in which the reduction of tert-butyl hydroperoxide with benzyl thiol to afford dibenzyl disulfide and tert-butyl alcohol was performed under standard conditions and monitored by HPLC. Although the diselenides showed generally poor catalytic activity, allyl selenides proved more effective. In particular, allyl 3-hydroxypropyl selenide (25) rapidly generated 1,2-oxaselenolane Se-oxide (31) in situ by a series of oxidation and [2,3]sigmatropic rearrangement steps. The remarkably active cyclic seleninate 31 proved to be the true catalyst, reacting with the thiol via a postulated mechanism in which the thioseleninate 32 is first produced, followed by further thiolysis to selenenic acid 33 and oxidation-dehydration to regenerate 31. In contrast to catalysis with GPx, formation of the corresponding selenenyl sulfide 34 comprises a competing deactivation pathway in the catalytic cycle of 31, as a separate experiment revealed that authentic 34 was a much less effective catalyst than 31. 1,2-Oxaselenane Se-oxide (37), the six-membered homologue of 31, was formed similarly from allyl 4-hydroxybutyl selenide (26), but proved a less effective catalyst than 31. Compounds 31 and 37 are the first examples of unsubstituted monocyclic seleninate esters.

Selenium compounds

-

, (2008/06/13)

Selenium compounds, and a method of their preparation, are disclosed which have a structure that renders the compounds useful in immunoassays or in competitive protein binding assays wherein either radio-labeled selenium compounds or nonradioactive selenium compounds are used respectively, with radiologic or fluorometric analysis. One class of these compounds have the generalized structural formula of: STR1 wherein: X is hydrogen or oxo; R1 and R2, together, are ethylene, trimethylene, or 5,6-phenylene; R3 is alkylene of 1 to 6 carbons; R4 is alkyl or isoalkyl of 1 to 6 carbons, phenyl or benzyl; or R3 and R4 together are 1,2,3-propanetriyl; And n is 1 or 2. The compounds in the aforementioned structure are N-pyrrolidine derivatives wherein R1 and R2 together are ethylene; N-succinimdyl derivatives when R1 and R2 together are ethylene and the X groups are oxo groups; N-phthalimidyl derivatives when R1 and R2 are 5,6-phenylene and the X groups are oxo; and N-piperidyl compounds when R1 and R2 together are trimethylene. Another class of these compounds has the generic formula: STR2 wherein: R3, R4 and n are as previously defined.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7370-58-3